Clinical Scorecard: Complications of Sympathetic Ophthalmia in Pregnant Patients with Proliferative Diabetic Retinopathy: Diagnostic and Treatment Challenges
At a Glance
Category
Detail
Condition
Sympathetic Ophthalmia
Key Mechanisms
Bilateral granulomatous panuveitis mediated by T-cell reactivity against uveal antigens.
Target Population
Pregnant patients with proliferative diabetic retinopathy.
Care Setting
Ophthalmology and maternal-fetal medicine.
Key Highlights
Sympathetic ophthalmia incidence is approximately 0.1% after intraocular surgery.
Complications and worse visual outcomes are noted in eyes with both PDR and uveitis.
High-dose systemic corticosteroids are the mainstay of acute management.
Adalimumab is effective for managing noninfectious uveitis and facilitates corticosteroid tapering.
Monitoring is crucial during pregnancy due to potential complications.
Guideline-Based Recommendations
Diagnosis
Clinical diagnosis of sympathetic ophthalmia based on symptoms and examination findings.
Management
Initiate high-dose intravenous methylprednisolone followed by tapering.
Consider adalimumab as a steroid-sparing agent.
Monitoring & Follow-up
Regular assessment of visual acuity and retinal status.
Risks
Systemic corticosteroids may cause hyperglycemia, especially in diabetic patients.
Patient & Prescribing Data
Pregnant patients with a history of poorly controlled diabetes and ocular trauma.
Combination of corticosteroids and adalimumab may optimize management while minimizing risks.
Clinical Best Practices
Prompt recognition and treatment of sympathetic ophthalmia are essential for preserving vision.
Multidisciplinary counseling is recommended for managing complex cases during pregnancy.
Joseph P. Shovlin, OD, FAAO, reviewed diagnosis, management, and emerging evidence related to chronic herpetic eye disease prevention at Optometry's Meeting 2026.
